EZH2 and cancer: This evidence together suggests a high potential for clinical application, through targeting the PVT1/EZH2 axis to regulate gene transcription (80), and further study may be needed to analysis the binding sites of PVT1 inside EZH2, facilitating the development anti-cancer therapies targeting the PVT1/EZH2 axis.